다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of Korean biological nursing science, v.23 no.4, 2021년, pp.298 - 307
박진영 (서울아산병원 간호부) , 최혜란 (울산대학교 임상전문간호학)
AI-Helper
Purpose: This study aimed to investigate the risk factors for cardiac implantable electronic device (CIED)-related infections within the first post-procedural year after CIED insertion. Methods: This study included 509 adult patients undergoing CIED implantation procedures between January 1, 2011 an...
Korea Disease Control and Prevention Agency. 2006-2019 acute cardiac arrest survey page[Internet]. Osong: Korea Disease Control and Prevention Agency; 2020 Dec [cited 2021 Sep 7]. Available from: http://www.kdca.go.kr/board/board.es?mida20503050000&bid0021&actview&list_no711768
Kuriachan VP, Sumner GL, Mitchell LB. Sudden cardiac death. Current Problems in Cardiology. 2015;40(4):133-200. https://doi.org/10.1016/j.cpcardiol.2015.01.002
Goldberger Z, Lampert R. Implantable cardioverter defibrillators expanding indications and technologies. The Journal of the American Medical Association. 2006;295(7):809-818. https://doi.org/10.1001/jama.295.7.809
Earley A, Persson R, Garlitski AC, Balk EM, Uhlig K. Effectiveness of implantable cardioverter defibrillators for primary prevention of sudden cardiac death in subgroups : a systematic review. Annals of Internal Medicine. 2014;160(2): 111-121. https://doi.org/10.7326/M13-1787
Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458-477. https://doi.org/10.1161/CIRCULATIONAHA.109.192665
Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the united states 1993 to 2008. Journal of the American College of Cardiology. 2011;58(10):1001-1006. https://doi.org/10.1016/j.jacc.2011.04.033
Kim YI. 2019 main surgery statistical yearbook page [Internet]. Wonju: National Health Insurance Service; 2020 Nov [cited 2021 Sep 8]. Available from: https://www.nhis.or.kr/nhis/together/wbhaec06800m01.do?modeview&articleNo10803657&article.offset0&articleLimit10
Quinn S, Elhadi M, Weedle R, Nolan P, Keane S, Murphy T, et al. 15 Cardiac implantable electronic device complications in a real-world setting. Heart. 2019;105:A13-A14. https://doi.org/10.1136/heartjnl-2019-ICS.15
Yang PS, Jeong JH, You SJ, Yu HT, Kim TH, Sung JH, et al. The burden and risk factors for infection of transvenous cardiovascular implantable electronic device: a nationwide cohort study. Korean Circulation Journal. 2019;49(8):742-752. https://doi.org/10.4070/kcj.2018.0361
Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clinic Proceedings. 2008;83(1):46-53. https://doi.org/10.4065/83.1.46
Lekkerkerker JC, van Nieuwkoop C, Trines SA, van der Bom JG, Bernards A, van de Velde ET, et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart. 2009;95(9):715-720. https://doi.org/10.1136/hrt.2008.151985
Sohail MR, Hussain S, Le KY, Dib C, Lohse CM, Friedman PA, et al. Risk factors associated with early- versus late-onset implantable cardioverter defibrillator infections. Journal of Interventional Cardiac Electrophysiology. 2011;31(2):171-183. https://doi.org/10.1007/s10840-010-9537-x
Darouiche RO. Treatment of infections associated with surgical implants. The New England Journal of Medicine. 2004;350(14):1422-1429. https://doi.org/10.1056/NEJMra035415
Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ. Mortality and cost associated with cardiovascular implantable electronic device infections. Archives of Internal Medicine. 2011;171(20):1821-1828. https://doi.org/10.1001/archinternmed.2011.441
Guha A, Maddox WR, Colombo R, Nahman NS, Kintziger KW, Waller JL, et al. Cardiac implantable electronic device infection in patients with end-stage renal disease. Heart Rhythm Society. 2015;12(12):2395-2401. https://doi.org/10.1016/j.hrthm.2015.08.003
Ann HW, Ahn JY, Jeon YD, Jung IY, Jeong SJ, Joung BY, et al. Incidence of and risk factors for infectious complications in patients with cardiac device implantation. International Journal of Infectious Diseases. 2015;36:9-14. https://doi.org/10.1016/j.ijid.2015.05.011
Sung SC. 2015 main surgery statistical yearbook page[Internet]. Seoul: National Health Insurance Service; 2016 Nov [cited 2021 Sep 8]. Available from: https://www.nhis.or.kr/nhis/together/wbhaec06800m01.do?modeview&articleNo 122272&article.offset0&articleLimit10
Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J, et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing and Clinical Electrophysiology. 2006;29(2):142-145. https://doi.org/10.1111/j.1540-8159.2006.00307.x
Johansen JB, Jorgensen OD, Moller M, Arnsbo P, Mortensen PT, Nielsen JC. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. European Heart Journal. 2011;32(8):991-998. https://doi.org/10.1093/eurheartj/ehq497
Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116(12):1349-1355. https://doi.org/10.1161/CIRCULATIONAHA.106.678664
de Oliveira JC, Martinelli M, Nishioka SAD, Varejao T, Uipe D, Pedrosa AAA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: Results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circulation: Arrhythmia and Electrophysiology. 2009;2(1):29-34. https://doi.org/10.1161/CIRCEP.108.795906
Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Risk factor analysis of permanent pacemaker infection. Clinical Infectious Diseases. 2007;45(2):166-173. https://doi.org/10.1086/518889
Margey R, McCann H, Blake G, Keelan E, Galvin J, Lynch M, et al. Contemporary management of and outcomes from cardiac device related infections. Europace. 2010;12(1):64-70. https://doi.org/10.1093/europace/eup362
Nery PB, Fernandes R, Nair GM, Sumner GL, Ribas CS, Divakara Menon SM, et al. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. Journal of Cardiovascular Electrophysiology. 2010;21(7):786-790. https://doi.org/10.1111/j.1540-8167.2009.01690.x
Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Management and outcome of permanent pacemaker and implantable cardioverter defibrillator infections. Journal of the American College of Cardiology. 2007;49(18):1851-1859. https://doi.org/10.1016/j.jacc.2007.01.072
Landolina M, Gasparini M, Lunati M, Iacopino S, Boriani G, Bonanno C, et al. Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database. Circulation. 2011;123(22):2526-2535. https://doi.org/10.1161/CIRCULATIONAHA.110.015024
Raad D, Irani J, Akl EG, Choueiri S, Azar E, Abboud J, et al. Implantable electrophysiologic cardiac device infections: a risk factor analysis. European Journal of Clinical Microbiology & Infectious Diseases. 2012;31(11):3015-3021. https://doi.org/10.1007/s10096-012-1655-1
Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. Journal of Clinical Epidemiology. 1996;49(12):1373-1379. https://doi.org/10.1016/S0895-4356(96)00236-3
Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code for Biology and Medicine. 2008;3:17. https://doi.org/10.1186/1751-0473-3-17
Metais M, Hebrard A, Duparc A, Mondoly P, Delay M, Lepage B, et al. Cardiac implantable devices: surveillance of surgical site infections and assessment of professional pratices. Archives of Cardiovascular Diseases. 2011;104(5):325-331. https://doi.org/10.1016/j.acvd.2011.02.003
Healy CA, Carrillo RG. Renal disease in patients undergoing cardiac implantable electronic device extraction for infectious and non-infectious indications. The Journal of Innovations in Cardiac Rhythm Management. 2015;6(5):2014-2017. https://doi.org/10.19102/icrm.2015.060503
Habib A, Irfan M, Baddour LM, Le KY, Anavekar NS, Lohse CM, et al. Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections. Europace. 2013;15(2):227-235. https://doi.org/10.1093/europace/eus292
Mittal S, Shaw RE, Michel K, Palekar R, Arshad A, Musat D, et al. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope. Heart Rhythm. 2014;11(4):595-601. https://doi.org/10.1016/j.hrthm.2013.12.013
Spinler SA, Nawarskas JJ, Foote EF, Sabapathi D, Connors JE, Marchlinski FE. Clinical presentation and analysis of risk factors for infectious complications of implantable cardioverter-defibrillator implantations at a university medical center. Clinical Infectious Diseases. 1998;26(5):1111-1116. https://doi.org/10.1086/520299
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.